Citi downgraded both AbbVie (NYSE:ABBV) and Merck (NSE:PROR) to Neutral in separate notes Wednesday, citing long-term growth concerns and late-stage pipeline limitations as headwinds for the ...

The report provides extensive insights into over 180 companies and 200 drugs in the PD-1 and PD-L1 inhibitors market. This comprehensive resource focuses on treatment assessments by product type, ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

IO Biotech was named to Fast Company’s World’s Most Innovative Companies of 2025 list for its potentially game-changing approach to immune-modulatory cancer vaccines, earning its place on the coveted ...

Belrestotug showed underwhelming efficacy outcomes in mid-stage studies of non-small cell lung cancer and head and neck ...

There are many problems with the plan. It ignores the fact, for instance, that generic drugs, which make up 90% of ...

Leap Therapeutics is laying off half of its staff as the company narrows the focus of its lead cancer drug against the ...

Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may ...

Trump signed a similar executive order in the final weeks of his first term, but a court order later blocked the rule from ...

Following President Trump’s announcement on Monday of an executive order to cut prescription drug prices, experts share some of the most expensive medications.

Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...

President Donald Trump has issued a new executive order giving pharmaceutical companies a 30-day window to voluntarily lower ...